This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through June 3, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Levi Strauss (LEVI) Stock Moves -0.04%: What You Should Know
by Zacks Equity Research
In the latest trading session, Levi Strauss (LEVI) closed at $25.03, marking a -0.04% move from the previous day.
Levi Strauss (LEVI) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Levi Strauss (LEVI) closed the most recent trading day at $24.62, moving +1.9% from the previous trading session.
Levi Strauss (LEVI) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Levi Strauss (LEVI) closed the most recent trading day at $24.40, moving +0.04% from the previous trading session.
Levi Strauss (LEVI) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Levi Strauss (LEVI) closed at $25.51, marking a -1.81% move from the previous day.
Levi Strauss (LEVI) Stock Moves -0.71%: What You Should Know
by Zacks Equity Research
Levi Strauss (LEVI) closed the most recent trading day at $25.20, moving -0.71% from the previous trading session.
Is Asbury Automotive Group (ABG) Stock Outpacing Its Retail-Wholesale Peers This Year?
by Zacks Equity Research
Here is how Asbury Automotive Group (ABG) and Levi Strauss (LEVI) have performed compared to their sector so far this year.
Zacks Market Edge Highlights: Lululemon, Macy's, Target, American Eagle Outfitters and Levi Strauss
by Zacks Equity Research
Zacks Market Edge Highlights: Lululemon, Macy's, Target, American Eagle Outfitters and Levi Strauss
The Best Retail Stocks to Buy Now
by Tracey Ryniec
The retail industry has a lot of shining stars including Lululemon, Macy's, Target, American Eagle and Levi Strauss.
The Zacks Analyst Blog Highlights: Levi Strauss, Boot Barn, Capri Holdings and Canada Goose
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Levi Strauss, Boot Barn, Capri Holdings and Canada Goose
4 Apparel Stocks to Buy Ahead of the Holiday Season
by Ritujay Ghosh
Apparel retailers like Levi Strauss & Co. (LEVI), Boot Barn Holdings (BOOT) and Capri Holdings (CPRI) are likely to benefit this holiday season.
Macy's (M) Boosts Staff's Morale Via Wage Raise & Benefits
by Zacks Equity Research
Macy's (M) makes constant efforts to boost guests' shopping experiences. Also, the company unveils benefits programs for its colleagues.
Buckle (BKE) Continues to Impress With Stellar Sales Run
by Zacks Equity Research
Buckle (BKE) is consistently witnessing an impressive sales performance. Solid gains from the company's women's and men's merchandise categories are contributing to its results.
Wall Street Analysts Believe Levi Strauss (LEVI) Could Rally 29%: Here's is How to Trade
by Zacks Equity Research
The consensus price target hints at a 29.1% upside potential for Levi Strauss (LEVI). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
The Zacks Analyst Blog Highlights: Levi Strauss, Boot Barn, Tilly's and Torrid Holdings
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Levi Strauss, Boot Barn, Tilly's and Torrid Holdings
Capri Holdings' (CPRI) Q2 Earnings Top Estimates, FY22 View Up
by Zacks Equity Research
Capri Holdings' (CPRI) second-quarter results reflect better revenue performance across all three luxury houses. Management now envisions revenues to be approximately $5.4 billion for fiscal 2022.
4 Apparel Stocks Set to Dazzle This Holiday Season
by Ritujay Ghosh
Apparel retailers like Levi Strauss & Co. (LEVI), Boot Barn Holdings (BOOT) and Tilly's (TLYS) are likely to benefit this holiday season.
Under Armour (UAA) Beats on Q3 Earnings, Raises '21 Outlook
by Zacks Equity Research
Under Armour's (UAA) third-quarter performance reflects brand strength and better execution. The company now envisions full-year 2021 revenues to be up approximately 25%.
The Zacks Analyst Blog Highlights: Boot Barn, Levi Strauss, Best Buy, Macy's and Tilly's
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Boot Barn, Levi Strauss, Best Buy, Macy's and Tilly's
Zacks Industry Outlook Highlights: Levi Strauss, Boot Barn, Genesco, Chico's FAS and Tilly's
by Zacks Equity Research
Zacks Industry Outlook Highlights: Levi Strauss, Boot Barn, Genesco, Chico's FAS and Tilly's
5 Retail-Apparel & Shoes Stocks to Buy on Splendid Industry Trends
by Sumit Singh
Launch of newer styles, customization options and digital expansion have brightened up the prospects of the Zacks Retail - Apparel And Shoes industry. Levi Strauss (LEVI), Boot Barn (BOOT), Genesco (GCO), Chico's (CHS) and Tilly's (TLYS) are set to gain from the improving industry fundamentals.
The Zacks Analyst Blog Highlights: Levi Strauss, Lululemon, Sonos and Callaway Golf
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Levi Strauss, Lululemon, Sonos and Callaway Golf
Holiday Retail Sales to Hit Record High: 6 Stocks to Buy
by Ritujay Ghosh
Retailers with a strong online presence like Levi Strauss & Co. (LEVI), Best Buy (BBY) and Tilly's (TLYS) are likely to benefit this holiday season
Levi Strauss (LEVI) Crossed Above the 50-Day Moving Average: What That Means for Investors
by Zacks Equity Research
Good things could be on the horizon when a stock surpasses the 50-Day simple moving average. How should investors react?
3 Cheap Stocks to Buy Now for Big Upside in November
by Benjamin Rains
With this backdrop, investors might want to consider buying strong stocks that have yet to return to their previous highs. Today, we also focused on stocks trading for around $30 or less...
Wall Street Analysts See a 39% Upside in Levi Strauss (LEVI): Can the Stock Really Move This High?
by Zacks Equity Research
The consensus price target hints at a 39.1% upside potential for Levi Strauss (LEVI). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.